Plus   Neg

Stock Alert: The Chemours Company Close To 52-week High

Shares of specialty chemical company The Chemours Company (CC) are climbing more than 5% Monday morning, continuing momentum on better-than-expected second-quarter results reported on July 30.

The stock is currently trading at $19.49, close to its 52-week high of $20.23.

Adjusted earnings per share in the second quarter of $0.18 beat the average estimate of analysts polled by Thomson Reuters at $0.1.

Net sales for the quarter, however, decreased to $1.093 billion from $1.408 billion last year due to the impact of COVID-19 on global demand.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT